Key result
MiR-208b-3p knockdown reduces Myh7 and activates NRF2 pathways after ~20-fold elevation in failing hearts.
Why the study?
The regulatory mechanisms distinguishing adaptive from maladaptive cardiac stress responses remain incompletely defined, prompting investigation into the role of the intronic MYH7 microRNA miR-208b-3p in cardiac stress adaptation.
Does miR-208b-3p regulate MYH7 remodeling, redox signaling, and cardiomyocyte survival in stress-adapted Mlp−/− mice and human cardiomyopathy?
Does miR-208b-3p regulate MYH7 remodeling, redox signaling, and cardiomyocyte survival in stress-adapted Mlp−/− mice and human cardiomyopathy?
This preclinical study identifies miR-208b-3p as an upstream regulator of cardiac stress adaptation that links myosin heavy chain remodeling with ATM and NRF2-related redox survival pathways.
Should not yet alter cardiomyopathy management; extends preclinical links between miR-208b-3p, myosin remodeling, and redox defense.
Background Cardiac stress induces MYH6 -to- MYH7 remodeling and activates redox-defense programs, but the regulatory mechanisms that distinguish adaptive from maladaptive stress responses remain incompletely defined. We investigated the role of miR-208b-3p, an intronic MYH7 microRNA, in cardiac stress adaptation. Methods and Results We integrated myocardial transcriptomic and small RNA sequencing from stress-adapted Mlp −/− mice and human cardiomyopathy to identify stress-adaptive programs associated with preserved myocardial viability and complemented these analyses with in vivo miR-208b-3p inhibition and cellular gain-of-function experiments. Mlp −/− hearts exhibited marked Myh7 induction accompanied by an ≈20-fold increase in miR-208b-3p, whereas this coordinated response was blunted in human end-stage dilated and ischemic cardiomyopathies. In vivo inhibition of miR-208b-3p selectively reduced Myh7 , without altering Myh6 or baseline cardiac function. This reduction in Myh7 occurred without induction of established Myh7 transcriptional repressors, and miR-208b-3p gain-of-function similarly reduced MYH7 while suppressing several canonical repressors, indicating that its relationship with MYH7 extends beyond the established repressor pathway. miR-208b-3p inhibition activated oxidative stress, NRF2, autophagy, and cell-survival pathways. Oxidative stress transiently suppressed miR-208b-3p, with rebound induction after stress removal, whereas antioxidant treatment increased its expression. Pharmacological NRF2 activation did not alter miR-208b-3p, whereas miR-208b-3p gain-of-function reduced oxidative stress-associated apoptotic signaling and suppressed ATM, a predicted target and regulator of cellular stress responses, supporting an upstream role for miR-208b-3p in stress adaptation. Conclusions MiR-208b-3p is a dynamic component of cardiac stress adaptation that links myosin remodeling with redox and survival responses. Its regulation of ATM and association with NRF2-related stress responses support an upstream role in coordinating cellular adaptation to cardiac stress.
No takes yet. Share an insight, caveat, or question.
Hossain et al. (2026) studied Dilated cardiomyopathy and ischemic cardiomyopathy. LNA-modified miR-208b-3p antagomir vs. Scramble control was evaluated on Myocardial miR-208b-3p expression, Myh7 expression, and cardiac function (LVEF) (p=<0.001). MiR-208b-3p increased ~20-fold in Mlp-/- hearts, negatively correlated with LVEF (r=-0.713, p<0.001), and >70% in vivo knockdown selectively reduced Myh7 and activated NRF2 redox pathways.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: